Herpes DNAemia and TTV Viraemia in Intensive Care Unit Critically Ill Patients: A Single-Centre Prospective Longitudinal Study

• Published in: Frontiers in immunology Vol. 12; p. 698808
• Main Authors: Mallet, François, Diouf, Léa, Meunier, Boris, Perret, Magali, Reynier, Frédéric, Leissner, Philippe, Quemeneur, Laurence, Griffiths, Andrew D, Moucadel, Virginie, Pachot, Alexandre, Venet, Fabienne, Monneret, Guillaume, Lepape, Alain, Rimmelé, Thomas, Tan, Lionel K, Brengel-Pesce, Karen, Textoris, Julien
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers 02.11.2021; Frontiers Media S.A
• Subjects: acquired infection; Adult; Aged; Critical Illness; DNA Virus Infections - complications; DNA Virus Infections - epidemiology; DNA Virus Infections - virology; Female; Herpesviridae - isolation & purification; Herpesviridae Infections - complications; Herpesviridae Infections - epidemiology; Herpesviridae Infections - virology; herpesviruses; Hospital Mortality; Humans; Immunology; intensive care unit; Intensive Care Units; Life Sciences; Longitudinal Studies; Male; Middle Aged; mortality; Prospective Studies; sepsis; Shock, Septic - epidemiology; Shock, Septic - etiology; Torque teno virus - isolation & purification; TTV; Viremia - complications; Viremia - epidemiology; Viremia - virology; immune response; biomarkers; TTV; herpesviruses; mortality; intensive care unit; sepsis; acquired infection
• ISSN: 1664-3224; 1664-3224
• DOI: 10.3389/fimmu.2021.698808

We analysed blood DNAemia of TTV and four herpesviruses (CMV, EBV, HHV6, and HSV-1) in the REAnimation Low Immune Status Marker (REALISM) cohort of critically ill patients who had presented with either sepsis, burns, severe trauma, or major surgery. The aim was to identify common features related to virus and injury-associated pathologies and specific features linking one or several viruses to a particular pathological context. Overall and individual viral DNAemia were measured over a month using quantitative PCR assays from the 377 patients in the REALISM cohort. These patients were characterised by clinical outcomes [severity scores, mortality, Intensive Care Unit (ICU)-acquired infection (IAI)] and 48 parameters defining their host response after injury (cell populations, immune functional assays, and biomarkers). Association between viraemic event and clinical outcomes or immune markers was assessed using χ -test or exact Fisher's test for qualitative variables and Wilcoxon test for continuous variables. The cumulative incidence of viral DNAemia increased from below 4% at ICU admission to 35% for each herpesvirus during the first month. EBV, HSV1, HHV6, and CMV were detected in 18%, 12%, 10%, and 9% of patients, respectively. The incidence of high TTV viraemia (>10,000 copies/ml) increased from 11% to 15% during the same period. Herpesvirus viraemia was associated with severity at admission; CMV and HHV6 viraemia correlated with mortality during the first week and over the month. The presence of individual herpesvirus during the first month was significantly associated (p < 0.001) with the occurrence of IAI, whilst herpesvirus DNAemia coupled with high TTV viraemia during the very first week was associated with IAI. Herpesvirus viraemia was associated with a lasting exacerbated host immune response, with concurrent profound immune suppression and hyper inflammation, and delayed return to immune homeostasis. The percentage of patients presenting with herpesvirus DNAemia was significantly higher in sepsis than in all other groups. Primary infection in the hospital and high IL10 levels might favour EBV and CMV reactivation. In this cohort of ICU patients, phenotypic differences were observed between TTV and herpesviruses DNAemia. The higher prevalence of herpesvirus DNAemia in sepsis hints at further studies that may enable a better understanding of host determinants of herpesvirus viral reactivation. Furthermore, our data suggest that EBV and TTV may be useful as additional markers to predict clinical deterioration in ICU patients.